Reports of Biochemistry
and Molecular Biology
Fri, Apr 19, 2024
[Archive]
Volume 9, Issue 4 (Vol.9 No.4 Jan 2021)
rbmb.net 2021, 9(4): 435-441 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hoseinkhani Z, Rastegari-Pouyani M, Tajemiri F, Yari K, Mansouri K. Association of vitamin D receptor polymorphisms (Fok1 (rs2228570), ApaI (rs7975232), BsmI (rs1544410), and TaqI (rs731236)) with gastric cancer among Kurdish population from west of Iran. rbmb.net 2021; 9 (4) :435-441
URL: http://rbmb.net/article-1-542-en.html
URL: http://rbmb.net/article-1-542-en.html
Zohreh Hoseinkhani 
, Mohsen Rastegari-Pouyani , Farahnaz Tajemiri , Kheirollah Yari , Kamran Mansouri *
, Mohsen Rastegari-Pouyani , Farahnaz Tajemiri , Kheirollah Yari , Kamran Mansouri *
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract: (3390 Views)
Background: The association of 1,25-dihydroxy vitamin D3 (1,25(OH)2D3) and its receptor, vitamin D receptor (VDR), with cancer types have been studied. However, there are controversial findings regarding the association of specific VDR polymorphisms with different kinds of cancers. In the current study, we investigated the association of VDR polymorphisms (Fok1 (rs2228570), ApaI (rs7975232), BsmI (rs1544410), and TaqI (rs731236)) with the risk of gastric cancer in a Kurdish population of Kermanshah in Iran for the first time.
Methods: In this case-control study, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used in 99 gastric cancer patients and 100 healthy subjects as controls.
Results: The frequencies of f (FokI), b (BsmI), t (TaqI), and a (ApaI) alleles were: 55.6%, 27.3%, 62.1%, and 44.95% in the patient group, respectively and 42%, 29.5%, 54.5%, and 46.0% in the control group, respectively. Analysis of the results indicated that there was a positive association between the frequency of FokI genotypes with gastric cancer risk (p= 0.021). However, no statistically significant association of BsmI, Taq1, and ApaI polymorphisms of VDR was detected in gastric patients when compared with healthy individuals.
Conclusions: VDR-FokI polymorphism could increase the risk of GC development and predispose to the disease by mechanisms.
Methods: In this case-control study, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used in 99 gastric cancer patients and 100 healthy subjects as controls.
Results: The frequencies of f (FokI), b (BsmI), t (TaqI), and a (ApaI) alleles were: 55.6%, 27.3%, 62.1%, and 44.95% in the patient group, respectively and 42%, 29.5%, 54.5%, and 46.0% in the control group, respectively. Analysis of the results indicated that there was a positive association between the frequency of FokI genotypes with gastric cancer risk (p= 0.021). However, no statistically significant association of BsmI, Taq1, and ApaI polymorphisms of VDR was detected in gastric patients when compared with healthy individuals.
Conclusions: VDR-FokI polymorphism could increase the risk of GC development and predispose to the disease by mechanisms.
Type of Article: Original Article |
Subject:
Molecular Biology
Received: 2020/08/6 | Accepted: 2020/09/1 | Published: 2021/03/8
Received: 2020/08/6 | Accepted: 2020/09/1 | Published: 2021/03/8
References
1. Guo L-L, Song C-H, Wang P, Dai L-P, Zhang J-Y, Wang K-J. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol. 2015;21(41):11680-7. [DOI:10.3748/wjg.v21.i41.11680] [PMID] [PMCID]
2. Al-Bayaty MK, Abass SA-R, Al-Marjani MF. E-Cadherin Protein as a Potential Marker for Gastric Cancer and Its Association with Helicobacter Pylori-Induced Gastritis and Gastric Ulcer. Rep Biochem Mol Biol. 2019;8(3):269-277.
3. Kazemi E, Kahrizi D, Moradi M, Sohrabi M, Amini S, Mousavi S, et al. Association between Helicobacter pylori hopQI genotypes and human gastric cancer risk. Cell Mol Biol (Noisy-le-grand). 2016;62(1):6-9.
4. Moradi M-T, Yari K, Rahimi Z, Kazemi E, Shahbazi M. Manganese superoxide dismutase (MnSOD Val-9Ala) gene polymorphism and susceptibility to gastric cancer. Asian Pac J Cancer Prev. 2015;16(2):485-8. [DOI:10.7314/APJCP.2015.16.2.485] [PMID]
5. Mittal RD, Manchanda PK, Bhat S, Bid HK. Association of vitamin‐D receptor (Fok‐I) gene polymorphism with bladder cancer in an Indian population. BJU Int. 2007;99(4):933-7. [DOI:10.1111/j.1464-410X.2007.06657.x] [PMID]
6. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000;22(2):203-17. [DOI:10.1093/oxfordjournals.epirev.a018033] [PMID]
7. Naveh-Many T, Marx R, Keshet E, Pike J, Silver J. Regulation of 1, 25-dihydroxyvitamin D3 receptor gene expression by 1, 25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest. 1990;86(6):1968-75. [DOI:10.1172/JCI114931] [PMID] [PMCID]
8. Mostafa-Hedeab G, Sabry D, Abdelaziz GM, Ewaiss M, Adli N, Fathy W. Influence of vitamin D receptor gene polymorphisms on response to pegylated interferon in chronic hepatitis B Egyptian patients. Rep Biochem Mol Biol. 2018;6(2):186-196.
9. Wen Y, Da M, Zhang Y, Peng L, Yao J, Duan Y. Alterations in vitamin D signaling pathway in gastric cancer progression: A study of vitamin D receptor expression in human normal premalignant, and malignant gastric tissue. Int J Clin Exp Pathol. 2015;8(10):13176-84.
10. Colston K, Colston MJ, Feldman D. 1, 25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981;108(3):1083-6. [DOI:10.1210/endo-108-3-1083] [PMID]
11. Thorne J, Campbell MJ. The vitamin D receptor in cancer: Symposium on 'Diet and cancer'. Proceedings of the Nutrition Society. 2008;67(2):115-27. [DOI:10.1017/S0029665108006964] [PMID]
12. Abd-Elsalam EA-E, Ismaeil NA, Abd-Alsalam HS. Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women. Tumor Biol. 2015;36(8):6425-31. [DOI:10.1007/s13277-015-3332-3] [PMID]
13. Langdahl BL, Gravholt CH, Brixen K, Eriksen E. Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest. 2000;30(7):608-17. [DOI:10.1046/j.1365-2362.2000.00686.x] [PMID]
14. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Research. 2007;9(1):R9. [DOI:10.1186/bcr1642] [PMID] [PMCID]
15. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004;10(16):5472-81. [DOI:10.1158/1078-0432.CCR-04-0206] [PMID]
16. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996;56(18):4108-10.
17. Hoseinkhani Z, Khodarahmi R, Sadeghalvad M, Norooznezhad F, Mansouri K. CYP2C9* 1* 2 and VKORC1-1639 AA Polymorphisms Correlation with Warfarin Dose Requirement: A Case Report. Journal of Reports in Pharmaceutical Sciences. 2018;7(1):88-91.
18. Cheng W-C, Tsai K. The vitamin D receptor start codon polymorphism (Fok1) and bone mineral density in premenopausal women in Taiwan. Osteoporos Int. 1999;9(6):545-9.
https://doi.org/10.1007/s001980050274 [DOI:10.1007/s001980050183]
19. Macdonald HM, McGuigan FE, Stewart A, Black AJ, Fraser WD, Ralston S, et al. Large‐scale population‐based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res. 2006;21(1):151-62. [DOI:10.1359/JBMR.050906] [PMID]
20. Köstner K, Denzer N, Mueller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29(9):3511-36.
21. Cheskis B, Freedman LP. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol. 1994;14(5):3329-3338. [DOI:10.1128/MCB.14.5.3329] [PMID] [PMCID]
22. Freedman L, Arce V, Perez Fernandez R. DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol. 1994;8(3):265-73.
https://doi.org/10.1210/me.8.3.265 [DOI:10.1210/mend.8.3.8015545] [PMID]
23. Nakajima S, Hsieh J-C, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, et al. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol. 1994;8(2):159-72.
https://doi.org/10.1210/me.8.2.159 [DOI:10.1210/mend.8.2.8170472] [PMID]
24. Acikbas I, Sanlı B, Tepeli E, Ergin S, Aktan S, Bagci H. Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patients. Med Sci Monit. 2012;18(11):CR661-6. [DOI:10.12659/MSM.883544] [PMID] [PMCID]
25. Grabiec M, Walentowicz P, Sadłecki P, Walentowicz-Sadłecka M. The role of vitamin D in the carcinogenesis of breast and ovarian cancer. Ginekologia polska. 2013;84(4):305-8. [DOI:10.17772/gp/1581] [PMID]
26. Cong L, Wang W-b, Liu Q, Du J-j. FokI polymorphism of the vitamin D receptor gene is associated with susceptibility to gastric cancer: a case-control study. Tohoku J Exp Med. 2015;236(3):219-24. [DOI:10.1620/tjem.236.219] [PMID]
27. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Rezvani ME. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south‐eastern Iranian patients. J Gastroenterol Hepatol. 2010;25(1):90-3. [DOI:10.1111/j.1440-1746.2009.05950.x] [PMID]
28. Mozaffarizadeh H, Hakimian M, Salehi M, Moazam E, Behjati M, Keshvari M, et al. The Relationship Between Breast Cancer and VDR Gene Polymorphisms. Archives of Breast Cancer. 2018:5;26-31.
29. Serrano D, Gnagnarella P, Raimondi S, Gandini S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev. 2016;25(1):85-96. [DOI:10.1097/CEJ.0000000000000132] [PMID] [PMCID]
30. Simmons J, Mullighan C, Welsh K, Jewell D. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut. 2000;47(2):211-4. [DOI:10.1136/gut.47.2.211] [PMID] [PMCID]
31. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2010;14(1):15-23.
32. Vidigal VM, Silva TD, de Oliveira J, Pimenta CAM, Felipe AV, Forones NM. Genetic polymorphisms of vitamin D receptor (VDR), CYP27B1 and CYP24A1 genes and the risk of colorectal cancer. Int J Biol Markers. 2017;32(2):e224-e230. [DOI:10.5301/jbm.5000248] [PMID]
33. de Jesus Martins D, Matos GC, Loiola RS, D'Annibale V, Corvelo T. Relationship of vitamin D receptor gene polymorphisms in Helicobacter pylori gastric patients. Clin Exp Gastroenterol. 2018;11:19-27. [DOI:10.2147/CEG.S143332] [PMID] [PMCID]
34. Singh K, Gandhi S, Batool R. A Case-Control Study of the Association between Vitamin D Levels and Gastric Incomplete Intestinal Metaplasia. Nutrients. 2018;10(5):629. [DOI:10.3390/nu10050629] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
